The current RNAZ market cap is 410.97k. The company's latest EPS is USD -27.9947 and P/E is -0.02.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.95M | -5.53M | -4.9M | -5.13M | -5.33M |
Net Income | -4.29M | -5.13M | -4.82M | -4.34M | -5.3M |
Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -457k | -726k | -6.15M | -18.67M |
Net Income | -607k | -2.34M | -6.84M | -17.57M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Assets | 12.02M | 7.59M | 5.59M | 5.88M | 10.23M |
Total Liabilities | 3.77M | 4.35M | 5.83M | 3.79M | 5.79M |
Total Equity | 8.24M | 3.24M | -237k | 2.09M | 4.44M |
Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 204k | 1.06M | 22.94M | 7.59M |
Total Liabilities | 1.31M | 4.46M | 2.53M | 4.35M |
Total Equity | -1.11M | -3.41M | 20.4M | 3.24M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Operating | -11.74M | -15.76M | -4.51M | -8.91M | -12.41M |
Investing | -73k | -101k | -13k | -31k | -35k |
Financing | -219k | 5k | 1.18M | 7.54M | 14.93M |
Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -509k | -493k | -5.27M | -15.76M |
Investing | N/A | N/A | -252k | -101k |
Financing | 500k | 1.12M | 25.52M | 5k |
Market Cap | 410.97k |
Price to Earnings Ratio | -0.02 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.08 |
Price to Book Ratio | 0.13 |
Dividend Yield | - |
Shares Outstanding | 627.44k |
Average Volume (1 week) | 116.75k |
Average Volume (1 Month) | 282.66k |
52 Week Change | -99.74% |
52 Week High | 371.68 |
52 Week Low | 0.56 |
Spread (Intraday) | 0.02 (3.49%) |
Company Name | TransCode Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.transcodetherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.